US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

58 deals · US$48bndisclosed · Life Sciences · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Sep 2026 Standard BioTools Mass Cytometry business Standard BioToolsElement BiosystemsAsset saleAnnounced5.5Life Sciences+1 Maynard Nexsen (buy-side)
Sep 2026 Lifecore Biomedical –Webster Equity PartnersAcquisitionAnnounced663.7Pharma Services+2 Bourne Capital Partners (sell-side)Craig-Hallum (sell-side)Ballard Spahr (sell-side)Zukerman Gore Brandeis & Crossman (sell-side)Morgan Stanley (buy-side)Goodwin (buy-side)
Sep 2026 Agilex Biolabs HealiusNovotech Health HoldingsAcquisitionAnnounced114.0Healthcare+1 UBS (sell-side)Mallesons (sell-side)
Sep 2026 Firma Data Services Firma Clinical ResearchEverest Clinical ResearchAsset saleCompleted–Clinical Trial Services+1 Edgemont Partners (sell-side)
Sep 2026 Cellipont Bioservices ––MergerCompleted–Pharma Services+2 William Blair
Sep 2026 Prolytix EdgewaterVIONAcquisitionAnnounced–Pharma Services+1 Stout (sell-side)
Aug 2026 Precision Medicine Group BlackstoneMcKessonAcquisitionAnnounced2,250.0Clinical Trial Services+1 Debevoise & Plimpton (sell-side)Centerview Partners (sell-side)Davis Polk (buy-side)
Aug 2026 BWXT Medical business BWX TechnologiesNordic CapitalAsset salePending800.0Radiopharmaceuticals+2 Solomon Partners (sell-side)Stikeman Elliott (sell-side)Kirkland & Ellis (buy-side)McCarthy Tétrault (buy-side)
Aug 2026 MIMETAS –BRUKERAcquisitionCompleted–Life Sciences+1 Raymond James
Aug 2026 NovaBone Products HalmaIsto BiologicsAcquisitionCompleted60.0Medtech+1 Baird (buy-side)
Jul 2026 Avisoft Bioacoustics –Lafayette InstrumentAcquisitionCompleted–Life Sciences+2 Vedder Price (buy-side)RSM (buy-side)
Jul 2026 MYOS Corp –PetIQAcquisitionCompleted–Supplements+2 Davis Graham (sell-side)Davis Polk (buy-side)Lincoln International (buy-side)
Jul 2026 ArisGlobal Nordic CapitalDassault SystèmesAcquisitionAnnounced2,000.0Healthcare Software+2 Evercore (sell-side)Jefferies (sell-side)Kirkland & Ellis (sell-side)Sullivan & Cromwell (buy-side)
Jul 2026 BioLife Solutions –RepligenAcquisitionAnnounced1,500.0Life Sciences+1 Centerview Partners (sell-side)K&L Gates (sell-side)Goodwin (buy-side)Perella Weinberg Partners (buy-side)Goldman Sachs (buy-side)
Jul 2026 Personalis –Tempus AIAcquisitionAnnounced1,900.0Diagnostics+2 Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side)
Jul 2026 Life Sciences & Healthcare segment ClarivateAltarisAsset saleAnnounced600.0Healthcare Software+2 Davis Polk (sell-side)Morgan Stanley (sell-side)Hogan Lovells Cadwalader (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Kirkland & Ellis (buy-side)
Jul 2026 DCM BioServices –Surplus SolutionsAcquisitionAnnounced–Life Sciences+1 McDermott Will & Schulte (buy-side)
Jul 2026 MeiraGTx Holdings –Oberland Capital ManagementStakeAnnounced–Biotech+1 Latham & Watkins (sell-side)
Jul 2026 Momentum Life Sciences –Parthenon Capital PartnersStakeCompleted–Healthcare Software+1 William Blair
Jul 2026 LaCorium Health founders of LaCorium HealthPrestige Consumer HealthcareAcquisitionCompleted–Healthcare+1 Addisons (sell-side)Pitcher Partners (buy-side)
Jul 2026 B Medical Systems AzentaThelema S.à r.l.Asset saleCompleted–Medtech+1 William Blair
Jun 2026 Bio-Techne –Merck KGaAAcquisitionPending11,300.0Life Sciences+1 Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side)
Jun 2026 Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program Sangamo TherapeuticsEli Lilly and CompanyAsset saleCompleted–Biotech+1 Raymond JamesPaul, Weiss (buy-side)
Jun 2026 Simulations Plus –Affiliates of AltarisAcquisitionAnnounced375.0Life Sciences+2 Morgan Stanley (sell-side)Procopio, Cory, Hargreaves & Savitch (sell-side)Bass, Berry & Sims (buy-side)Truist Securities (buy-side)J.P. Morgan (buy-side)Kirkland & Ellis (buy-side)Latham & Watkins (buy-side)
Jun 2026 Ignite Proteomics AditxtProposed Ignite Proteomics Inc. holding companyMergerPending150.0Life Sciences+2 Ladenburg Thalmann
Jun 2026 Kalderos –Model NAcquisitionAnnounced–Healthcare Software+2 Kirkland & Ellis (buy-side)
Jun 2026 kneat.com –Thoma Bravo, L.P.AcquisitionPending453.6Vertical SaaS+1 Kirkland & Ellis (buy-side)
Jun 2026 Helio Health Group –WestView Capital PartnersStakeCompleted–AI+1 Latham & Watkins (buy-side)
May 2026 Ennov Group –Bregal SagemountStakeAnnounced–Healthcare Software+2 Proskauer RoseGoodwin (buy-side)
May 2026 Sutter Instrument Corp. –Lafayette InstrumentAcquisitionCompleted–Manufacturing+2 EC M&A (sell-side)Donahue Fitzgerald (sell-side)Akerman (buy-side)RSM (buy-side)
May 2026 Regenity Biosciences –CinvenStakeAnnounced–Medtech+1 Baird (sell-side)
Apr 2026 XOMA Royalty –Ligand PharmaceuticalsAcquisitionCompleted739.0Specialty finance and leasing+2 Leerink Partners (sell-side)H.C. Wainwright & Co. (sell-side)Gibson Dunn (sell-side)Stifel (buy-side)Citi (buy-side)Paul Hastings (buy-side)Collected Strategies (buy-side)
Apr 2026 Certara Regulatory and Medical Writing business CertaraVeristatAsset saleAnnounced135.0Pharma Services+1 Perella Weinberg Partners (sell-side)Troutman Pepper Locke (sell-side)Guggenheim Securities (buy-side)McDermott Will & Schulte (buy-side)
Apr 2026 EpiVax –SV Health InvestorsAcquisitionAnnounced–Pharma Services+2 Morgan Lewis (buy-side)
Apr 2026 Thermo Fisher Scientific's microbiology division Thermo Fisher ScientificAstorgAsset saleAnnounced1,075.0Diagnostics+1 Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side)
Apr 2026 TriNetX –Regeneron PharmaceuticalsStakeCompleted–Healthcare Software+2 William Blair
Apr 2026 Celerion H.I.G. Capital affiliateTHL PartnersAcquisitionAnnounced–Pharma Services+2 LazardKirkland & Ellis (buy-side)Paul, Weiss (buy-side)
Mar 2026 Stratis Group –Nexus HealthAcquisitionAnnounced–Accounting, legal and consulting+1 Clearsight Advisors (sell-side)Pillsbury Winthrop Shaw Pittman (sell-side)
Mar 2026 Biocare Medical –Agilent TechnologiesAcquisitionAnnounced950.0Diagnostics+1 Sullivan & Cromwell (buy-side)
Mar 2026 Lonza Capsules & Health Ingredients division Lonza Group AGLone Star FundsAsset saleAnnounced–Pharmaceutical Manufacturing+2 Kirkland & Ellis (buy-side)
Feb 2026 Bruder Consulting & Venture Group –Dark Horse Consulting GroupAcquisitionCompleted–Accounting, legal and consulting+1 Goodwin (sell-side)Edgemont Partners (sell-side)
Feb 2026 Laysan Bio –Gannet BioChemAcquisitionAnnounced–Pharma Services+2 Goodwin (buy-side)
Feb 2026 Dutscher Group –Vivo CapitalAcquisitionAnnounced–Life Sciences+1 Sidley Austin (buy-side)Mayer Brown (buy-side)
Jan 2026 Ganymede –Apprentice.ioAcquisitionAnnounced–Software+1 Cooley (buy-side)
Jan 2026 StarLIMS –Turn/River CapitalStakeAnnounced–Software+2
Jan 2026 Verana Health ––MergerAnnounced–Healthcare Software+2 BofA Securities (sell-side)Wilson Sonsini Goodrich & Rosati (buy-side)
Jan 2026 Aktana –PharmaForceIQAsset saleAnnounced–Healthcare Software+2 Canaccord Genuity
Jan 2026 PTC Therapeutics' remaining royalty on Roche's Evrysdi PTC TherapeuticsRoyalty PharmaAsset saleAnnounced240.0Specialty finance and leasing+2 Goodwin (buy-side)
Jan 2026 Evidinno Outcomes Research –United BioSourceAcquisitionCompleted–Pharma Services+2 Fairmount Partners (sell-side)
Jan 2026 BioRender –Dimension CapitalStakeAnnounced900.0Software+2 Sidley Austin (sell-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built